NASDAQ:KITE (KITE) (KITE) Stock Price, News & Analysis → Only a fool would buy Nvidia today… (From Porter & Company) (Ad) Free KITE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$179.79▼$179.7950-Day Range N/A52-Week Range$39.82▼$179.99VolumeN/AAverage Volume1.65 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (KITE) alerts: Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> About (KITE) Stock (NASDAQ:KITE)Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products to target and kill cancer cells. The Company offers engineered autologous cell therapy, which is an approach to the treatment of cancer. Its therapy involves modifying a patient's T cells outside the patient's body, or ex vivo, causing the T cells to express chimeric antigen receptors (CARs), or T cell receptors (TCRs), and then reinfusing the engineered T cells back into the patient. Its lead product candidate, KTE-C19, is a CAR-based therapy that targets the CD19 antigen, a protein expressed on the cell surface of B-cell lymphomas and leukemias. The Company is conducting a registrational Phase II clinical trial (ZUMA-1) of KTE-C19 in patients with relapsed or refractory aggressive diffuse large B cell lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL), or transformed follicular lymphoma (TFL).Read More Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> KITE Stock News HeadlinesMarch 27, 2024 | msn.comBlack Kite, Parakeet Rescued From Vijay Chowk And Air Force Station In DelhiMarch 27, 2024 | msn.comPolice arrest prime suspect, aides in Faisalabad kite twine incidentMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 27, 2024 | msn.comPunjab police register 245 cases against kite makers, flyersMarch 27, 2024 | finance.yahoo.comNucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of DirectorsMarch 26, 2024 | msn.comConcrete in Life Photo of the Year: Picture of kite flyers wins top prizeMarch 26, 2024 | msn.comCM terms kite flying 'blood sport'March 26, 2024 | yahoo.comWatch: Craziest Wave Ever Surfed on a Hydrofoil Kite?March 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 25, 2024 | msn.comCM orders crackdown against kite-flying after death of youth in FaisalabadMarch 24, 2024 | msn.comHundreds reach new heights at Kite FestivalMarch 24, 2024 | msn.comCrackdown on kite flying continuesMarch 23, 2024 | msn.comPakistan: Punjab CM Maryam Nawaz Terms Kite Flying A ‘Blood Sport’ After Young Motorcyclist Dies Due To Metal StringMarch 22, 2024 | msn.comKite flyers have enjoyed March 2024 so farMarch 22, 2024 | markets.businessinsider.comFirst patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosisMarch 22, 2024 | msn.comReview: The Kite Runner a gripping tale of betrayal and redemptionMarch 21, 2024 | msn.comMore onshore wind farms in Wales unlikely to halt red kite recovery – studyMarch 21, 2024 | finance.yahoo.comBlack Kite’s Fifth Annual Third-Party Breach Report Highlights Ripple Effects of Cyber-Ecosystem BreachesMarch 19, 2024 | uk.sports.yahoo.comKatie Dabson and the power of the GB Formula Kite girlsMarch 19, 2024 | finanznachrichten.deShandong Office of Hong Kong Business Daily: Weifang Kite and Yangjiabu Woodblock New Year Paintings Appear in San Francisco, USAMarch 19, 2024 | msn.comFestival of the Kite, Dinosaur World Live, and More Top Things To Do in Los Angeles This WeekendMarch 18, 2024 | msn.com3rd annual kite festival flies into Huntington Beach in Murrells InletMarch 16, 2024 | msn.comFynn Goat, one of Australia's best young kite surfers, is getting on board the wing foilMarch 15, 2024 | msn.comUniversity Kiwanis Club hosts kite flying event at Kiwanis ParkMarch 15, 2024 | theguardian.comRamadan prayers and kite flying: photos of the day – FridayMarch 15, 2024 | uk.news.yahoo.comOwl left with droopy wing after getting tangled in kite stringMarch 14, 2024 | msn.comKite-flying competition, Easter egg hunt at Baton Rouge park: When, whereSee More Headlines Receive KITE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (KITE) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2017Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:KITE CUSIPN/A CIK1510580 Webwww.kitepharma.com Phone+1-310-8249999FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesArie S. BelldegrunExecutive Chairman of the Board, President, Chief Executive Officer, FounderPaul L. JenkinsonChief Financial OfficerCynthia M. ButittaChief Operating OfficerDavid Chang M.D. Ph.D.Executive Vice President - Research and Development, Chief Medical OfficerHelen S. KimExecutive Vice President - Business DevelopmentTimothy L. MooreExecutive Vice President - Technical OperationsChristine CassianoSenior Vice President - Corporate Communications and Investor RelationsBio & Compensation - Jian Irish Ph.D.Senior Vice President - Supply ChainBio & Compensation - Jeffrey Wiezorek M.D.Senior Vice President - Clinical DevelopmentShawn Cline TomaselloChief Commercial OfficerMore Executives KITE Stock Analysis - Frequently Asked Questions How were (KITE)'s earnings last quarter? (KITE) (NASDAQ:KITE) announced its earnings results on Tuesday, February, 28th. The biopharmaceutical company reported ($1.70) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.75) by $0.05. The biopharmaceutical company had revenue of $4.90 million for the quarter, compared to analyst estimates of $5.74 million. The company's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.54) EPS. What other stocks do shareholders of (KITE) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (KITE) investors own include Puma Biotechnology (PBYI), (MDVN) (MDVN), BioMarin Pharmaceutical (BMRN), Incyte (INCY), First Solar (FSLR), Dynavax Technologies (DVAX), United Airlines (UAL), Juno Therapeutics (JUNO), Array Technologies (ARRY) and bluebird bio (BLUE). This page (NASDAQ:KITE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceFed launches fourth dollar overhaulStansberry Research“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (KITE) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.